Stay updated on Immunotherapy in Stage IV Melanoma Patients Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy in Stage IV Melanoma Patients Clinical Trial page.

Latest updates to the Immunotherapy in Stage IV Melanoma Patients Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page; no substantive study details appear to change.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2; removed the older government funding/operating status notice (v3.4.1). These are routine site maintenance updates that do not alter the study details.SummaryDifference0.4%

- Check41 days agoChange DetectedA site-wide funding notice was added (notifying about a lapse in government funding and directing users to cc.nih.gov and opm.gov) and the page revision tag updated from v3.4.0 to v3.4.1, with no changes to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedThe update adds a Show glossary option and a new PDF study protocol (Study Protocol and Statistical Analysis Plan), along with expanded Study Documents and Locations/Investigators sections. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference61%

- Check62 days agoChange DetectedRevision: v3.3.4 was added and v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedLocations section added with state-specific sites (Illinois, Iowa, Kansas, North Carolina, and Tennessee) and page revision updated to v3.3.3. The HHS Vulnerability Disclosure link and several location sections were removed.SummaryDifference0.6%

Stay in the know with updates to Immunotherapy in Stage IV Melanoma Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy in Stage IV Melanoma Patients Clinical Trial page.